Clinical Trial Update: CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of CS0159 for primary biliary cholangitis in Chinese patients is currently active but not recruiting, sponsored by Cascade Pharmaceutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• CS0159

Snippet

Sponsor: Cascade Pharmaceuticals, Inc | Conditions: Primary Biliary Cholangitis (PBC) | Phase 2 | Status: ACTIVE_NOT_RECRUITING